Azetidin-2-one derivatives as serine protease inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

540362, 540357, 540359, 540360, C07D20508, C07D20509, C07D24700, A61K 31395

Patent

active

052506770

ABSTRACT:
The present invention relates to new 3-guanidinoalkyl-2-azetidinones of the formula ##STR1## wherein: U and W can be the same or different and are selected from the group consisting of hydrogen and an amino protecting group;

REFERENCES:
patent: 4623645 (1986-11-01), Doherty et al.
patent: 4637999 (1987-01-01), Doherty et al.
patent: 4680391 (1987-07-01), Firestone et al.
patent: 4699904 (1987-10-01), Doherty et al.
patent: 4717722 (1988-01-01), Doherty et al.
patent: 4845088 (1989-07-01), Doherty et al.
Doherty, et al., Cephalosporin Antibiotics can be Modified to Inhibit Human Leukecyte Elastase, Nature, 322, p. 192 (1986).
Gianfranco, C., et al. Stereocontrolled Total Synthesis of Chiral Building Block (3S,4R)-3-[(R)-1-Hydroethyl]-4-Acetyloxy-Azetidin-2-One; A Useful Synthon for the Synthesis of (+)-Thienamycin, Carbapenems and Penems. Tetrahedron Letters, 26, No. 7, pp. 937-940, (1985).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Azetidin-2-one derivatives as serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azetidin-2-one derivatives as serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidin-2-one derivatives as serine protease inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1005257

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.